Big pharma in TNBC

40 of the 50 largest pharma companies have at least one TNBC activity: 463 programs, deals, investments and trial collaborations.

Timeline

Companies: the 50 largest pharma companies by prior-year prescription revenue (published ranking). A subsidiary or venture arm counts for its parent only while it belonged to it. Click a mark for details; click a company in Involvement by company to focus every view.

Drug typeSmall moleculeOligonucleotideGene / cell therapyAntibody / biologicUndisclosedRepurposingClick a mark for details
StatusActiveCompletedEndedDiscontinuedUnknown

Involvement by company

Drug typeSmall moleculeOligonucleotideGene / cell therapyAntibody / biologicUndisclosedRepurposingClick a company to focus every view
StatusActiveCompletedEndedDiscontinuedUnknown
Activities of each top-50 pharma company by type
Company
1
23
2
30
3
39
4
16
5
2
6
47
7
47
8
42
9
6
10
32
12
15
13
16
14
3
15
12
16
15
17
6
18
9
20
6
21
1
22
8
23
9
24
1
25
3
26
6
29
8
30
1
32
1
33
1
35
4
37
2
38
6
39
9
41
7
42
22
43
2
44
2
46
1
47
1
49
1
50
1

Programs, deals and trial support

Drug typeSmall moleculeOligonucleotideGene / cell therapyAntibody / biologicUndisclosedRepurposingChips sorted by Pharma 50 rank
StatusActiveCompletedEndedDiscontinuedUnknown
Programs, deals and trial support by activity type and stage
ActivityPreclinicalINDPhase 1Phase 2Phase 3+Approved
In-house program
Acquired program
Partnership
Discontinued program
Academic trial support
Generics of the standard-of-care drug

Investments

Drug typeSmall moleculeGene / cell therapyAntibody / biologicChips sorted by year
StatusActiveEndedUnknown
Investments by round stage
ActivityFounding & seedSeries ASeries BSeries C & later privateRound not disclosed
Investment